hyperphosphatemia
Advertisement
The FDA approved Velphoro (sucroferric oxyhydroxide) for hyperphosphatemia in patients with CKD as young as age 9.
Patients with end-stage renal disease on maintenance hemodialysis commonly develop hyperphosphatemia, a complication ...
In dialysis-dependent patients with end-stage kidney disease (ESKD), hyperphosphatemia is treated with phosphate ...
Patients with chronic kidney disease (CKD) and hyperphosphatemia undergoing dialysis are at increased risk for ...
Kidney Week 2020
...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.